More hospitals part of plasma transfusion trial to treat COVID-19 with antibodies

The first two COVID-19 patients in Canada to receive plasma transfusions rich in antibodies are showing signs of improvement as the experimental treatment expands to trials in more than a dozen sites in Ontario and Quebec.